New Ultrasound Technique Detects Placental Pathologies
|
By MedImaging International staff writers Posted on 07 Jun 2021 |

Image: Ultrasoundof the umbilical artery can identify placenta lissues (Photo courtesy of Getty Images)
A new study suggests that ultrasound wave reflections in the umbilical artery (UA) can predict fetal placental circulation problems.
Researchers at the Hospital for Sick Children (Toronto, Canada), Memorial University of Newfoundland (MUN; St. John’s, Canada), Mount Sinai Hospital (Toronto, Canada), and other institutions conducted a study involving 241 pregnant women between the 26th and 32nd weeks of pregnancy. Standard clinical Doppler ultrasound of the UA was performed, and using a computational procedure, the Doppler waveforms were decomposed into a pair of forward and backward propagating waves.
The results included 36 women whom were diagnosed with maternal vascular malperfusion (MVM) and 16 with fetal vascular malperfusion (FVM), with wave reflections were significantly elevated in women with either MVM or FVM pathology. In contrast, standard umbilical and uterine artery pulsatility indices were only elevated in the MVM group, and there were no differences between women with FVM and controls. After the women gave birth, the diagnoses were verified by to physical examination of the placentas delivered. The study was published on May 4, 2021, in eBioMedicine.
“Measurement of wave reflections in the UA, combined with standard clinical ultrasound parameters, has the potential to improve the diagnostic performance of UA Doppler to detect placental vascular pathology,” concluded senior author John Sled, PhD, of The Hospital for Sick Children in Toronto, and colleagues. “Identifying women with FVM pathology is particularly challenging prenatally and future investigations will determine if women at risk of this specific placental disease could benefit from this novel diagnostic technique.”
Placental pathology is present in over half of cases of fetal growth restriction and stillbirth, with MVM the most common placental disorder. FVM is a less common, but is much more difficult to diagnose prenatally, and is almost always only recognized by pathological examination. This may be because the underlying intermittent umbilical cord obstruction is only loosely associated with cord hyper-coiling, and routine ultrasounds do not search for evidence of umbilical cord disease.
Related Links:
Hospital for Sick Children
Memorial University of Newfoundland
Mount Sinai Hospital
Researchers at the Hospital for Sick Children (Toronto, Canada), Memorial University of Newfoundland (MUN; St. John’s, Canada), Mount Sinai Hospital (Toronto, Canada), and other institutions conducted a study involving 241 pregnant women between the 26th and 32nd weeks of pregnancy. Standard clinical Doppler ultrasound of the UA was performed, and using a computational procedure, the Doppler waveforms were decomposed into a pair of forward and backward propagating waves.
The results included 36 women whom were diagnosed with maternal vascular malperfusion (MVM) and 16 with fetal vascular malperfusion (FVM), with wave reflections were significantly elevated in women with either MVM or FVM pathology. In contrast, standard umbilical and uterine artery pulsatility indices were only elevated in the MVM group, and there were no differences between women with FVM and controls. After the women gave birth, the diagnoses were verified by to physical examination of the placentas delivered. The study was published on May 4, 2021, in eBioMedicine.
“Measurement of wave reflections in the UA, combined with standard clinical ultrasound parameters, has the potential to improve the diagnostic performance of UA Doppler to detect placental vascular pathology,” concluded senior author John Sled, PhD, of The Hospital for Sick Children in Toronto, and colleagues. “Identifying women with FVM pathology is particularly challenging prenatally and future investigations will determine if women at risk of this specific placental disease could benefit from this novel diagnostic technique.”
Placental pathology is present in over half of cases of fetal growth restriction and stillbirth, with MVM the most common placental disorder. FVM is a less common, but is much more difficult to diagnose prenatally, and is almost always only recognized by pathological examination. This may be because the underlying intermittent umbilical cord obstruction is only loosely associated with cord hyper-coiling, and routine ultrasounds do not search for evidence of umbilical cord disease.
Related Links:
Hospital for Sick Children
Memorial University of Newfoundland
Mount Sinai Hospital
Latest Ultrasound News
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
- Pain-Free Breast Imaging System Performs One Minute Cancer Scan
- Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Channels
Radiography
view channel
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read more
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read moreMRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read more
Hybrid AI System Improves Early Lung Cancer Detection on CT
Early lung cancer often presents as tiny nodules on computed tomography (CT) that are difficult to distinguish from normal tissue, leading to delayed diagnoses. Missed or late findings limit timely intervention... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







